Skip navigation

Cost controls help Pfizer, Merck weather weak quarter

(Reuters) - Big Pharma is still relying on belt-tightening to prop up financial results.Full story

Big pharma's prescription for profits

  Barbara Ryan, FTI Consulting, breaks down the second quarter numbers on Pfizer and Merck and provides an outlook on which companies have the best drugs in the pipeline.

Pharma companies navigating 'patent cliffs'

  Barbara Ryan, FTI Consulting, provides a preview of Pfizer and Merck's earnings, and discusses how both pharma giants have improved shareholder value through M&A.

Sponsored Links

Articles

Analyst downgrades Merck on Januvia sales worries

Merck drug to reverse anesthesia delayed again at FDA

Merck says FDA needs more time for post-surgery drug review

U.S. FDA cancels advisory committee on Merck's drug sugammadex

Why Merck Is Poised to Pop

News Summary: Merck sleep drug approval delayed

Markets Big Three-Day Run Comes to an End

South Africa's Aspen in $1 billion deal with Merck

Germany's Merck sees liquid crystals momentum slowing in second half

Wall St. ends higher in late rebound

Video

  Very busy earnings week

CNBC's Julia Boorstin looks at next week's earnings reports, including BP, Chevron, Chrysler, Merck and Comcast.

  Next Week's Earnings: AAPL, T & more

Wall Street has a lot to look forward to with McDonald's, Apple, AT&T, Pfizer and Merck reporting earnings next week. CNBC's Seema Mody reports.

  You Asked for It Trades

The FMHR traders reveal their plays on the top stocks lighting up the Twitterfeed, including Verizon, Merck, Lockheed Martin, and Southwest Airlines.

  Gold Bull's Bold Call

The Fast Money traders provide their plays on Merck, Microsoft and Best Buy. And Rick Rule, Sprout Asset Management, explains why he thinks gold prices are due for a "technical recovery."

  Merck Shares Spike

The FMHR traders debate how to play Yum! Brands after the company's China sales fell less-than-expected; and Steve Grasso of Stuart Frankel offers his opinion on whether Merck has more upside ahead.

advertisement | ad info

Related Photos

ATTENTION EDITORS - PICTURE KILL FOR TOR102 TRANSMITTED ON JULY 30, 2013 AT APPROXIMATELY 1330 GMT
ATTENTION EDITORS - PICTURE KILL FOR TOR102 TRANSMITTED ON JULY 30, 2013 AT APPROXIMATELY 1330 GMT

ATTENTION EDITORS - PICTURE KILL FOR TOR102 TRANSMITTED ON JULY 30, 2013 AT APPROXIMATELY 1330 GMT. THE LOGO IS FROM A COMPANY UNRELATED TO MERCK & CO WHO RELEASED THEIR QUARTERLY REVENUE FIGURES ON JULY 30. PLEASE REMOVE THE IMAGE FROM YOUR SYSTEM.TEMPLATE OUT

A general view shows the Merck facility in Rahway, New Jersey November 28, 2005. The international p..
A general view shows the Merck facility in Rahway, New Jersey November 28, 2005. The international p..

A general view shows the Merck facility in Rahway, New Jersey November 28, 2005.

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo
The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo from March 7, 2012. REUTERS/Alex Domanski/Files

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt
The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt March 7, 2012. REUTERS/Alex Domanski